6-EAPB

6-EAPB, also known as 1--N-ethylpropan-2-amine, is a potentially psychedelic and potentially entactogenic drug of the benzofuran class; it is structurally related to 6-APB and MDMA.

Pharmacology

Pharmacodynamics

6-EAPB is a potent monoamine reuptake inhibitor. It shows very low potency as a serotonin 5-HT_2A receptor agonist.

Society and culture

Legal status

As an N-ethyl derivative of 6-APB, 6-EAPB fell outside the scope of the Temporary Class Drug ban issued by the Home Office on June 10, 2013.
The ACMD has advised that 6-EAPB are moved to Class B, this came into action on 10 June 2014.